Concepedia

Heng Lin

HL

Statistics

Publications

16

Citations

2.2K

H-Index

13

Active since

2014

Affiliations

University of Michigan(Current)

Michigan Center for Translational Pathology

Howard Hughes Medical Institute

Michigan Medicine

First Affiliated Hospital of Fujian Medical University

Heng Lin is an author at University of Michigan specializing in oncology, medicine, and immunology.

Publications per year

2014–2025

16

Publications

16

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

Heng Lin, Shuang Wei, Elaine M. Hurt et al. · Journal of Clinical Investigation · 2018 · 602 citations · Full text

Medicine, Immunology, Oncology +17

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

Weimin Wang, Ilona Kryczek, Lubomír Dostál et al. · Cell · 2016 · 432 citations · Full text

Medicine, Immunology, Oncology +12

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

Gaopeng Li, Ilona Kryczek, Jutaek Nam et al. · Nature Cell Biology · 2021 · 225 citations · Full text

Life Sciences, Immunology, Oncology +14

Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy

Jing Li, Weichao Wang, Yajia Zhang et al. · Journal of Clinical Investigation · 2020 · 200 citations · Full text

Medicine, Genetics, Oncology +17

Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance

Heng Lin, Ilona Kryczek, Shasha Li et al. · Cancer Cell · 2021 · 156 citations · Full text

Medicine, Cancer Biology, Immunology +16

1–5 of 16